Locoregional Tumor Progression After Radiation Therapy Influences Overall Survival in Pediatric Patients With Neuroblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1161-1165

  Pai Panandiker, Atmaram S ^a   McGregor, Lisa ^a   Krasin, Matthew J ^a   Wu, Shengjie ^a   Xiong, Xiaoping ^a   Merchant, Thomas E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Locoregional failure; Neuroblastoma; overall survival; Pediatric; Radiation

Indexed keywords

COMPUTED TOMOGRAPHY; CURATIVE INTENT; LOCAL CONTROL; LOCOREGIONAL CONTROL; NEUROBLASTOMA; NEUROBLASTOMAS; OVERALL SURVIVAL; PEDIATRIC PATIENTS; RADIATION DOSE; RADIATION THERAPY; SITE FAILURES; STATISTICAL SIGNIFICANCE; SYSTEMIC THERAPY; TARGET VOLUMES; TREATMENT PLANNING; TUMOR CONTROL; TUMOR PROGRESSIONS;

COMPUTERIZED TOMOGRAPHY; IRRADIATION; PEDIATRICS; RADIOTHERAPY; TUMORS;

RADIATION;

(3 IODOBENZYL)GUANIDINE;

ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; MALE; METASTASIS; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; RADIATION DOSE; SEX DIFFERENCE; TREATMENT PLANNING; TUMOR GROWTH;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEUROBLASTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 77449091670     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.03.068     Document Type: Article

References (15)

1. Wolden S.L., Gollamudi S.V., Kushner B.H., et al. Local control with multimodality therapy for Stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 46 (2000) 969-974
2. George R.E., Li S., Medeiros-Nancarrow C., et al. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update. J Clin Oncol 24 (2006) 2891-2896
3. Adkins E.S., Sawin R., Gerbing R.B., et al. Efficacy of complete resection for high-risk neuroblastoma: A Children's Cancer Group study. J Pediatr Surg 39 (2004) 931-936
4. La Quaglia M.P., Kushner B.H., Heller G., et al. Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcome. J Pediatr Surg 29 (1994) 1162-1166
5. Haas-Kogan D.A., Swift P.S., Selch M., et al. Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 56 (2003) 28-39
6. Kremens B., Klingiel T., Herrmann F., et al. High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma. Med Pediatr Oncol 23 (1994) 470-475
7. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341 (1999) 1165-1173
8. Wambersie A., and Landberg T. ICRU report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50) (1999), International Commission on Radiation Units and Measurement, Bethesda, MD
9. Kushner B.H., O'Reilly R.J., Mandell L.R., et al. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 9 (1991) 274-279
10. Kushner B.H., Wolden S., LaQuaglia M.P., et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 19 (2001) 2821-2828
11. Schmidt M.I., Lal A., Seeger R.C., et al. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: A Children's Cancer Group Study. J Clin Oncol 23 (2005) 6474-6480
12. Children's Oncology Group. Phase III randomized trial of single vs. tandem myeloablative consolidation therapy for high-risk neuroblastoma. ANBL0532 (2007)
13. Grupp S.A., Stern J.W., Bunin N., et al. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 18 (2000) 2567-2575
14. Marcus KJ., Shamberg R., Litman H., et al. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 25 (2003) 934-940
15. Matthay KK., Atkinson J.B., Stram D.O., et al. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Children's Cancer Group pilot study. J Clin Oncol 11 (1993) 2226-2233